Chargement en cours...
Patient-derived xenografts: a promising resource for preclinical cancer research
Patient-derived xenograft tumors retain molecular and histopathological features of the originating tumor and are useful preclinical tools for drug discovery and assessment. We recently reported that ‘rapid’ engraftment of head and neck squamous cell carcinoma samples is highly prognostic and correl...
Enregistré dans:
| Publié dans: | Mol Cell Oncol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6370391/ https://ncbi.nlm.nih.gov/pubmed/30788424 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2018.1558684 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|